Precision Medicine: Clinical Tolerance to Hyperfibrinolysis Differs by Shock and Injury Severity.
Where this comes from
- Record sourced from PubMed, PMID 33214445.
- Also identified by DOI 10.1097/SLA.0000000000004548 and PMC identifier 8589450.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The definition of hyperfibrinolysis based on thrombelastogram LY30 measurements should vary with trauma patient characteristics, i.e., as anatomic injury or shock severity increase, the ability to tolerate even mild degrees of fibrinolysis is markedly reduced. This trend is independent of institutional practice patterns. The management of hyperfibrinolysis, particularly with anti-fibrinolytics administration, should be interpreted in the context of injury severity/shock and managed on an individual patient basis.
Medical subject headings
- Blood Coagulation Disorders
- Precision Medicine
- Shock
- Wounds and Injuries